-
1
-
-
84961946800
-
Recommendations for laboratory testing for acetyl fentanyl and patient evaluation and treatment for overdose with synthetic opioid
-
June 20; (accessed March 11, 2015).
-
Recommendations for laboratory testing for acetyl fentanyl and patient evaluation and treatment for overdose with synthetic opioid. CDC Health Alert Network, June 20, 2013; http://emergency.cdc.gov/han/han00350.asp (accessed March 11, 2015).
-
(2013)
CDC Health Alert Network
-
-
-
2
-
-
84961860988
-
-
Acetylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide). Drug Enforcement Administration, December 2013;(accessed March 11, 2015).
-
Acetylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide). Drug Enforcement Administration, December 2013; http://www.deadiversion.usdoj.gov/drug_chem_info/acetylfentanyl.pdf (accessed March 11, 2015).
-
-
-
-
3
-
-
84961915831
-
-
Press Release, N.C. Department of Health and Human Services. February 19, 2014;(accessed March 11).
-
DHHS Issues Health Advisory for Deadly New Synthetic Drug. Press Release, N.C. Department of Health and Human Services. February 19, 2014; http://www.ncdhhs.gov/pressrel/2014/2014-02-19_health_advisory.htm (accessed March 11, 2015).
-
(2015)
-
-
-
5
-
-
83155178035
-
Criminalistics: introduction to controlled substances
-
In: Karch SB, editor., 2nd edn. New York, NY: CRC Press
-
Bono JP. Criminalistics: introduction to controlled substances. In: Karch SB, editor. Drug abuse handbook, 2nd edn. New York, NY: CRC Press, 2007;21-2.
-
(2007)
Drug abuse handbook
, pp. 21-22
-
-
Bono, J.P.1
-
6
-
-
0013569183
-
General anesthetics
-
In: Brunton L, editor., 11th edn. San Diego, CA: McGraw-Hill Companies Inc
-
Evers AS, Crowder M, Balser JR. General anesthetics. In: Brunton L, editor. Goodman and Gilman's manual of pharmacology and therapeutics, 11th edn. San Diego, CA: McGraw-Hill Companies Inc, 2008;240.
-
(2008)
Goodman and Gilman's manual of pharmacology and therapeutics
, pp. 240
-
-
Evers, A.S.1
Crowder, M.2
Balser, J.R.3
-
7
-
-
77951889526
-
Carfentanil - an ultra potent opioid
-
George AV, Lu JJ, Pisano MV, Metz J, Erickson TB. Carfentanil - an ultra potent opioid. Am J Emerg Med 2010;28:530-2.
-
(2010)
Am J Emerg Med
, vol.28
, pp. 530-532
-
-
George, A.V.1
Lu, J.J.2
Pisano, M.V.3
Metz, J.4
Erickson, T.B.5
-
8
-
-
40149089875
-
Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues
-
Higashikawa Y, Suzuki S. Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicol 2008;26:1-5.
-
(2008)
Forensic Toxicol
, vol.26
, pp. 1-5
-
-
Higashikawa, Y.1
Suzuki, S.2
-
9
-
-
84961942142
-
Dependence studies of new compounds in the Rhesus monkey, rat, and mouse
-
editor., The Committee on Problems of Drug Dependence; 1987 June 14-19; Philadelphia, PA. NIDA Research Monograph 81, 1988.
-
Aceto M, Bowman E, Harris L, May E, Harris LS, editor. Dependence studies of new compounds in the Rhesus monkey, rat, and mouse. Proceedings of the 49th Annual Scientific Meeting, The Committee on Problems of Drug Dependence; 1987 June 14-19; Philadelphia, PA. NIDA Research Monograph 81, 1988.
-
Proceedings of the 49th Annual Scientific Meeting
-
-
Aceto, M.1
Bowman, E.2
Harris, L.3
May, E.4
Harris, L.S.5
-
10
-
-
0141794315
-
Analysis of fentanyl and norfentanyl in human plasma by liquid chromatography-tandem mass spectrometry using electrospray ionization
-
Day J, Slawson M, Lugo RA, Wilkins D. Analysis of fentanyl and norfentanyl in human plasma by liquid chromatography-tandem mass spectrometry using electrospray ionization. J Anal Toxicol 2003;27:513-6.
-
(2003)
J Anal Toxicol
, vol.27
, pp. 513-516
-
-
Day, J.1
Slawson, M.2
Lugo, R.A.3
Wilkins, D.4
-
11
-
-
34249740757
-
LC-MS/MS analysis of fentanyl and norfentanyl in a fatality due to application of multiple Durogesic transdermal therapeutic systems
-
Coopman V, Cordonnier J, Pien K, Van Varenbergh D. LC-MS/MS analysis of fentanyl and norfentanyl in a fatality due to application of multiple Durogesic transdermal therapeutic systems. Forensic Sci Int 2007;169:223-7.
-
(2007)
Forensic Sci Int
, vol.169
, pp. 223-227
-
-
Coopman, V.1
Cordonnier, J.2
Pien, K.3
Van Varenbergh, D.4
-
14
-
-
56449126995
-
Fentanyl postmortem redistribution: preliminary findings regarding the relationship among femoral blood and liver and heart tissue concentrations
-
Luckenbill K, Thompson J, Middleton O, Kloss J, Apple F. Fentanyl postmortem redistribution: preliminary findings regarding the relationship among femoral blood and liver and heart tissue concentrations. J Anal Toxicol 2008;32:639-43.
-
(2008)
J Anal Toxicol
, vol.32
, pp. 639-643
-
-
Luckenbill, K.1
Thompson, J.2
Middleton, O.3
Kloss, J.4
Apple, F.5
-
15
-
-
84878840369
-
Postmortem fentanyl concentrations: a review
-
McIntyre IM, Anderson DT. Postmortem fentanyl concentrations: a review. J Forensic Res 2012;3:157.
-
(2012)
J Forensic Res
, vol.3
, pp. 157
-
-
McIntyre, I.M.1
Anderson, D.T.2
-
16
-
-
84878876944
-
Should postmortem subclavian blood be considered a peripheral or central sample?
-
Molina DK, Hargrove VM. Should postmortem subclavian blood be considered a peripheral or central sample? Am J Forensic Med Pathol 2013;34:155-8.
-
(2013)
Am J Forensic Med Pathol
, vol.34
, pp. 155-158
-
-
Molina, D.K.1
Hargrove, V.M.2
-
17
-
-
65549133940
-
Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective
-
Dumas EO, Pollack GM. Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective. AAPS J 2008;10:537-51.
-
(2008)
AAPS J
, vol.10
, pp. 537-551
-
-
Dumas, E.O.1
Pollack, G.M.2
-
18
-
-
0031874618
-
Opioid tolerance: the clinical perspective
-
Collett BJ. Opioid tolerance: the clinical perspective. Br J Anaesth 1998;81:58-68.
-
(1998)
Br J Anaesth
, vol.81
, pp. 58-68
-
-
Collett, B.J.1
-
19
-
-
84863566623
-
Fentanyl: toxic or therapeutic? Postmortem and antemortem blood concentrations after transdermal fentanyl application
-
Andresen H, Gullans A, Veselinovic M, Anders S, Schmoldt A, Iwersen-Bergmann S, et al. Fentanyl: toxic or therapeutic? Postmortem and antemortem blood concentrations after transdermal fentanyl application. J Anal Toxicol 2012;36:182-94.
-
(2012)
J Anal Toxicol
, vol.36
, pp. 182-194
-
-
Andresen, H.1
Gullans, A.2
Veselinovic, M.3
Anders, S.4
Schmoldt, A.5
Iwersen-Bergmann, S.6
-
20
-
-
84883316348
-
Acetyl fentanyl overdose fatalities -Rhode Island, March-May 2013
-
Centers for Disease Control and Prevention (CDC). Acetyl fentanyl overdose fatalities -Rhode Island, March-May 2013. MMWR Morb Mortal Wkly Rep 2013;62:703-4.
-
(2013)
MMWR Morb Mortal Wkly Rep
, vol.62
, pp. 703-704
-
-
-
21
-
-
77954862955
-
Forced degradation of fentanyl: Identification and analysis of impurities and degradants
-
Garg A, Solas DW, Takahashi LH, Cassella JV. Forced degradation of fentanyl: Identification and analysis of impurities and degradants. J Pharm Biomed Anal 2010;53:325-34.
-
(2010)
J Pharm Biomed Anal
, vol.53
, pp. 325-334
-
-
Garg, A.1
Solas, D.W.2
Takahashi, L.H.3
Cassella, J.V.4
-
22
-
-
0030774527
-
Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions
-
Labroo RB, Paine MF, Thummel KE, Kharasch ED. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Drug Metab Dispos 1997;25:1072-80.
-
(1997)
Drug Metab Dispos
, vol.25
, pp. 1072-1080
-
-
Labroo, R.B.1
Paine, M.F.2
Thummel, K.E.3
Kharasch, E.D.4
-
23
-
-
0029813838
-
Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4
-
Feierman DE, Lasker JM. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4. Drug Metab Dispos 1996;24:932-9.
-
(1996)
Drug Metab Dispos
, vol.24
, pp. 932-939
-
-
Feierman, D.E.1
Lasker, J.M.2
-
24
-
-
84893580502
-
Quantitative measurement of acetyl fentanyl and acetyl norfentanyl in human urine by LC-MS/MS
-
Patton AL, Seely KA, Pulla S, Rusch NJ, Moran CL, Fantegrossi WE, et al. Quantitative measurement of acetyl fentanyl and acetyl norfentanyl in human urine by LC-MS/MS. Anal Chem 2014;86:1760-6.
-
(2014)
Anal Chem
, vol.86
, pp. 1760-1766
-
-
Patton, A.L.1
Seely, K.A.2
Pulla, S.3
Rusch, N.J.4
Moran, C.L.5
Fantegrossi, W.E.6
-
26
-
-
83455176022
-
A low blood volume LC-MS/MS assay for the quantification of fentanyl and its major metabolites norfentanyl and despropionyl fentanyl in children
-
Clavijo CF, Thomas JJ, Cromie M, Schniedewind B, Hoffman KL, Christians U, et al. A low blood volume LC-MS/MS assay for the quantification of fentanyl and its major metabolites norfentanyl and despropionyl fentanyl in children. J Sep Sci 2011;34:3568-77.
-
(2011)
J Sep Sci
, vol.34
, pp. 3568-3577
-
-
Clavijo, C.F.1
Thomas, J.J.2
Cromie, M.3
Schniedewind, B.4
Hoffman, K.L.5
Christians, U.6
-
28
-
-
84961897955
-
New or re-emerging drug: acetyl fentanyl
-
June.
-
Ogilivie L. New or re-emerging drug: acetyl fentanyl. ToxTalk 2013 June;37(2):14-5.
-
(2013)
ToxTalk
, vol.37
, Issue.2
, pp. 14-15
-
-
Ogilivie, L.1
-
29
-
-
84961897954
-
Fentanyl enzyme immunoassay
-
Pomona, CA: Immunalysis Corporation
-
Immunalysis Corporation. Fentanyl enzyme immunoassay. Immunalysis product insert. Pomona, CA: Immunalysis Corporation, 2013.
-
(2013)
Immunalysis product insert
-
-
|